Innovating Works

ENYO Pharma SA

Desconocido
CARE: Corona Accelerated R D in Europe ENYO PHARMA participó en un H2020: H2020-JTI-IMI2-2020-21-single-stage The Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) pandemic has emerged as the largest global health threat to humanity in thi...
2020-08-07 - 2025-03-31 | Financiado
DRIVE: Driving next generation autophagy researchers towards translation ENYO PHARMA participó en un H2020: H2020-MSCA-ITN-2017 The manipulation of autophagy has an enormous therapeutic potential to revolutionize the way we currently treat cancers, neurodegenerative d...
2017-08-31 - 2022-04-30 | Financiado
MIMESIS: A novel systems biology approach to develop preclinical assets from innovative drug discovery starti... ENYO PHARMA tramitó un H2020: H2020-SMEInst-2016-2017 Access to new medicines targeting unmet medical need is a challenge for both the Pharmaceutical industry and the member states of the Europe...
2016-11-15 - 2018-10-31 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.